Al­most three years af­ter whiff­ing in a con­fir­ma­to­ry study, Mer­ck touts new da­ta for Keytru­da in HCC

Keytru­da’s ac­cel­er­at­ed ap­proval in a com­mon form of liv­er can­cer looked shaky af­ter the drug failed on two sur­vival mea­sures in a con­fir­ma­to­ry study al­most …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER